For further information, check About vitiligo on the top menu.
Help us now 
Trials completed
Clinical trials icompleted
Trials completed
Essai de phase 3 avec le povorcitinib par voie orale dans les vitiligos diffus (adultes).
Etude PREVENT Vitiligo : traitement combiné greffe de suspension épidermique et de ruxolitinib topique pour les zones difficiles à traiter.
Etude du mécanisme d’action du ruxolitinib pour les atteintes génitales de vitiligo.
ERASE VITILIGO Early Repigmentation Approach for Stopping the Evolution of VITILIGO Prospective Multicentric Interventional Study With Blinded Evaluation (ERASE).
Study of the mode of action of ruxolitinib cream in vitiligo.
Etude BARVIT. Baracitinib par voie orale dans les vitiligos actifs.
Upadacitinib par voie orale dans les vitiligos étendus.
Gastroprotected Superoxide Dismutase in Combination With UVB
vs Placebo and UVB for Treating Vitiligo
ClinicalTrial Identifier : NCT03941808
Status : Trial completed - Results published
Status : Trial completed - Results published
Study of the role of intestinal and skin microbiome in vitiligo
Status : Trial completed - Results published
Repigmentation using apremilast and phototherapy in diffuse vitiligo
(RAPID Vitiligo)
ClinicalTrial Identifier : NCT03036995
Status : Trial completed - Results published
Status : Trial completed - Results published
Study of the role of innate lymphoid cells and natural killer cells
in immune activation of vitiligo – INNATE Vitiligo
ClinicalTrial Identifier : NCT03859518
Status : Trial completed - Results published
Status : Trial completed - Results published
